bullish
SK Biopharmaceuticals IPO Book-Building Results & Ramifications
389 Views19 Jun 2020 22:01
Yes, it is a new record. The competition rate is 836 to 1, which is the highest among the ₩500bil+ IPOs in Korea. The previous record-holder was...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- SK Biopharmaceuticals: KOSPI 200 Inclusion Event02 Jul 2020
- Do What the Locals Do - BUY Celltrion/Samsung Bio/SK Holdings on SK Biopharma Listing02 Jul 2020
- SK Biopharmaceuticals: Immediate Post IPO Float Is 13% (Not 5%)01 Jul 2020
- SK Biopharmaceuticals Valuation Issues17 Jun 2020
- SK Biopharmaceuticals IPO: Potential Overhang Issue by SK Holdings11 Jun 2020
- SK Biopharmaceuticals IPO: Betting on Early Inclusion in KOSPI 200?27 May 2020
x